1. Home
  2. BCAB vs LIVE Comparison

BCAB vs LIVE Comparison

Compare BCAB & LIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • LIVE
  • Stock Information
  • Founded
  • BCAB 2007
  • LIVE 1968
  • Country
  • BCAB United States
  • LIVE United States
  • Employees
  • BCAB N/A
  • LIVE N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • LIVE Other Specialty Stores
  • Sector
  • BCAB Health Care
  • LIVE Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • LIVE Nasdaq
  • Market Cap
  • BCAB 96.2M
  • LIVE 37.3M
  • IPO Year
  • BCAB 2020
  • LIVE N/A
  • Fundamental
  • Price
  • BCAB $2.08
  • LIVE $10.66
  • Analyst Decision
  • BCAB Strong Buy
  • LIVE
  • Analyst Count
  • BCAB 2
  • LIVE 0
  • Target Price
  • BCAB $6.00
  • LIVE N/A
  • AVG Volume (30 Days)
  • BCAB 1.6M
  • LIVE 7.6K
  • Earning Date
  • BCAB 11-08-2024
  • LIVE 12-18-2024
  • Dividend Yield
  • BCAB N/A
  • LIVE N/A
  • EPS Growth
  • BCAB N/A
  • LIVE N/A
  • EPS
  • BCAB N/A
  • LIVE N/A
  • Revenue
  • BCAB N/A
  • LIVE $463,644,000.00
  • Revenue This Year
  • BCAB N/A
  • LIVE $20.91
  • Revenue Next Year
  • BCAB N/A
  • LIVE N/A
  • P/E Ratio
  • BCAB N/A
  • LIVE N/A
  • Revenue Growth
  • BCAB N/A
  • LIVE 42.48
  • 52 Week Low
  • BCAB $1.14
  • LIVE $9.80
  • 52 Week High
  • BCAB $4.02
  • LIVE $28.45
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.80
  • LIVE 29.02
  • Support Level
  • BCAB $1.87
  • LIVE $9.85
  • Resistance Level
  • BCAB $2.13
  • LIVE $10.44
  • Average True Range (ATR)
  • BCAB 0.12
  • LIVE 0.62
  • MACD
  • BCAB 0.00
  • LIVE 0.01
  • Stochastic Oscillator
  • BCAB 68.90
  • LIVE 17.65

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail, which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

Share on Social Networks: